Heidelberg Pharma AG (HPHA) - Total Liabilities

Latest as of May 2025: €43.94 Million EUR ≈ $51.37 Million USD

Based on the latest financial reports, Heidelberg Pharma AG (HPHA) has total liabilities worth €43.94 Million EUR (≈ $51.37 Million USD) as of May 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Heidelberg Pharma AG annual equity growth to track the company's year-over-year net asset growth rate.

Heidelberg Pharma AG - Total Liabilities Trend (2016–2024)

This chart illustrates how Heidelberg Pharma AG's total liabilities have evolved over time, based on quarterly financial data. See Heidelberg Pharma AG free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.

Heidelberg Pharma AG Competitors by Total Liabilities

The table below lists competitors of Heidelberg Pharma AG ranked by their total liabilities.

Company	Country	Total Liabilities
ADC Therapeutics SA NYSE:ADCT	USA	$507.87 Million
Onde SA WAR:OND	Poland	zł370.55 Million
Teo Seng Capital Bhd KLSE:7252	Malaysia	RM240.17 Million
Deoleo S.A MC:OLE	Spain	€373.55 Million
Vieworks Co. Ltd KQ:100120	Korea	₩103.22 Billion
OrganiGram Holdings Inc TO:OGI	Canada	CA$149.50 Million
Waterco Ltd AU:WAT	Australia	AU$134.40 Million
Syncom Formulations (India) Limited NSE:SYNCOMF	India	Rs775.88 Million

Liability Composition Analysis (2016–2024)

This chart breaks down Heidelberg Pharma AG's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Heidelberg Pharma AG market cap and net worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	7.74	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	2.37	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.70	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Heidelberg Pharma AG's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Heidelberg Pharma AG (2016–2024)

The table below shows the annual total liabilities of Heidelberg Pharma AG from 2016 to 2024.

Year	Total Liabilities	Change
2024-11-30	€29.85 Million ≈ $34.90 Million	+42.08%
2023-11-30	€21.01 Million ≈ $24.57 Million	-38.08%
2022-11-30	€33.94 Million ≈ $39.68 Million	+125.75%
2021-11-30	€15.03 Million ≈ $17.58 Million	+123.39%
2020-11-30	€6.73 Million ≈ $7.87 Million	+0.49%
2019-11-30	€6.70 Million ≈ $7.83 Million	+26.22%
2018-11-30	€5.31 Million ≈ $6.20 Million	+18.81%
2017-11-30	€4.47 Million ≈ $5.22 Million	-18.58%
2016-11-30	€5.49 Million ≈ $6.41 Million	--

About Heidelberg Pharma AG

F:HPHA Germany Biotechnology

Market Cap

$133.46 Million

€114.15 Million EUR

Market Cap Rank

#18045 Global

#1691 in Germany

Share Price

€2.44

Change (1 day)

-3.94%

52-Week Range

€2.31 - €4.46

All Time High

€8.94